Summary
Lyme disease is a multisystem inflammatory disease caused by infection with Borrelia burgdorferi. Soon after the tick bite which transmits the infection, the pathognomonic skin rash erythema chronicum migrans occurs in 50 to 70% of patients, often with associated symptoms resembling a ‘summer cold’ or viral infection. Therapy for this stage of disease consists of 3 to 4 weeks of oral therapy. The agents currently used are: amoxicillin (500mg 3 or 4 times daily) with or without probenecid 500mg 3 times daily, doxycycline (100mg twice daily), or tetracycline (500mg 4 times daily). Longer duration therapy has never been evaluated and therefore is not currently indicated. Even patients with severe early manifestations of Lyme disease should be treated orally.
Later features of Lyme disease include carditis and neurological disease, which can occur days to approximately 9 months after the onset of illness, and arthritis and neurological disease which can occur weeks to years after the onset of the illness. Treatment at this stage is with 2 to 3 weeks of intravenous antibiotics, currently cefotaxime (3g every 12 hours), ceftriaxone (lg every 12 hours or 2g every day) and benzylpenicillin (14g in divided doses). There is no evidence that longer duration therapy is indicated or more efficacious. The exception to this suggestion is the patient with isolated facial seventh cranial nerve palsy; if such a patient has no other signs or symptoms to suggest Lyme disease and has normal spinal fluid, oral therapy is usually sufficient, although some physicians will give concomitant corticosteroids to hasten the resolution of the palsy.
Of major consequence to the practitioner and patient is the possibility that persistent symptoms (e.g. fibromyalgia) may be caused by a process which is no longer antibiotic-sensitive. Special care in the management of so-called ‘chronic Lyme disease’ is crucial lest the clinician prescribes prolonged or unending courses of antibiotics for such noninfectious problems.
Similar content being viewed by others
References
Ackermann R, Rehse-Kupper B, Gollmer E, Schmidt R. chronic neurologic manifestations of erythema migrans Borreliosis. Annals of the New York Academy of Sciences 539: 16–23, 1988
Ackley Jr A, Lupovici M. Lyme disease meningitis treated with tetracycline. Annals of Internal Medicine 105: 630–631, 1986
Afzelius A. Erythema chronicum migrans. Acta Dermato-Venereologica 2: 120–125, 1921
Alpert LI, Welch P, Fisher N. Gallium-positive Lyme disease myocarditis. Clinical Nuclear Medicine 10: 617, 1985
Artigao R, Torres G, Guerrero A, Jimenez-Mena M, Paredes MB. Irreversible complete heart block in Lyme disease. American Journal of Medicine 90: 531–533, 1991
Asbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodes-borneBorreliosis. Annals of the New York Academy of Sciences 539: 4–15, 1988
Bannwarth A. Chronische Lymphocytare Meningitis, entzuundliche Polyneuritis und ‘Rheumatismus’. Ein Beitrag zum Problem ‘Allergie und Nervensystem’. Archiv für Psychiatric und Nervenkrankheiten 113: 284–376, 1941
Bedell SE, Pastor BM, Cohen SI. Symptomatic high grade heart block in Lyme disease. Chest 79: 236–237, 1981
Benach JL, Bosler EM, Hanrahan JP, Coleman JL, Habicht GS, et al. Spirochetes isolated from the blood of two patients with Lyme disease. New England Journal of Medicine 308: 740–742, 1983
Benach JL, Bosler EM (Eds) Third International Symposium on Lyme Disease and related disorders. Annals of the New York Academy of Sciences 539: 1–513, 1988
Berger BW, Kaplan MH, Rotherberg IR, Barbour AG. Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. Journal of the American Academy of Dermatology 13: 444–449, 1989
Berger BW, Johnson RC. Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease. Journal of the American Academy of Dermatology 21: 1188–1191, 1989
Bialasiewicz AA, Ruprecht KW, Naumann GOH, Blenk H. Bilateral diffuse choroiditis and exudative retinal detachments with evidence of Lyme disease. American Journal of Ophthalmology 105: 419–420, 1988
Blaauw AA, van der Linden SJ, Kuiper H. Lyme carditis in the Netherlands. Annals of Internal Medicine 111: 261–262, 1989
Bojar M, Hercogova J, Valesova M, Jirous J. Cefotaxime in the treatment of Lyme Borreliosis. Presented at the Fourth European Congress of Clinical Microbiology in Nice, France, April 17–20, 1989
Buchwald A. Ein Fall von diffuser idiopathischer Haut-Atrophie. Archives of Dermatology and Syphilology 10: 553–556, 1883
Burckhardt B. Zur Frage der Follikel und Kreinzentrenbildung in der Haut. Frankfurter Zeitschrift für Pathologie 6: 352–359, 1911
Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, et al. Lyme disease — a tick-borne spirochetosis? Science 216: 1317–1320, 1982
Casans I, Villar A, Almenar V, Blanes A. Lyme myocarditis diagnosed by Indium 111 anti-myosin antibody scintigraphy. European Journal of Nuclear Medicine 15: 330–331, 1989
Clarke JR, Carlson RD, Sasaki CT, Pachner AR, Steere AC. Facial paralysis in Lyme disease. Laryngoscope 95: 1341–1345, 1985
Costello CM, Steere AC, Pinkerton RE, Feder Jr HM. A prospective study of tick bites in an endemic area for Lyme disease. Journal of Infectious Diseases 159: 136–139, 1989
Dattwyler RJ, Halperin JJ. Failure of tetracycline therapy in early Lyme disease. Arthritis and Rheumatism 30: 442–448, 1987
Dattwyler RJ, Halperin JJ, Pass H, Luft BJ. Ceftriaxone as effective therapy in refractory Lyme disease. Journal of Infectious Diseases 155: 1322–1325, 1987
Dattwyler DJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme Borreliosis — randomised comparison of ceftriaxone and penicillin. Lancet 1: 1191–1194, 1988
Dattwyler RJ, Volkman DJ, Conaty SM, Platkin SP, Luft BJ. Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 2: 1404–1406, 1990
de Koning J, Hoogkaamp-Korstanje JAA, van der Linde MR, Crijns HJGM. Demonstration of spirochetes in cardiac biopsies of patients with Lyme disease. Journal of Infectious Diseases 160: 150–153, 1989
Dlesk A, Bjarnason D, Goldberg J, Lee M, Washington W. Lyme disease (LD) presenting as seronegative rheumatoid arthritis (SNRA). Arthritis and Rheumatism 29: S31, 1986
Dlesk A, Broste SK, Harkins PG, McCarty PA, Mitchell PD. Lyme seropositivity (LS+) and pregnancy (PG) outcome in the absence of symptoms (Sx) of Lyme disease (LD). Arthritis and Rheumatism 32: S46, 1989
Dotevall L, Alestig K, Hanner P, Norkrans G, Hagberg L. The use of doxycycline in nervous sytem Borrelia burgdorferiinfection. Scandinavian Journal of Infectious Diseases (Suppl. 53): 74–79, 1988
Eichenfield AH, Goldsmith DP, Benach JL, Ross AH, Loeb FX, et al. Childhood Lyme arthritis: experience in an endemic area. Journal of Pediatrics 109: 753–760, 1986
Garin-Bujadoux C. Paralysie par les tiques. Journal de Médecine de Lyons 3: 765–767, 1922
Hansen K, Madsen JK. Myocarditis associated with tickborne Borrelia burgdorferiinfection. Lancet 2: 1323–1324, 1986
Hassler D, Zipperle G, Ackermann R, Lembke U, Heinrich F. Kardiale Beteilung auch bei der europaischen Erythema-migrans-Borreliose? Deutsch Medizinische Wochenschrift 112: 1506–1508, 1987
Hauser W. Zur Kenntnis der Akrodermatitis chronica atrophicans. Archives of Dermatology and Syphilology 199: 350–375, 1955
Heimlich HJ. Should we try malariotherapy for Lyme disease? New England Journal of Medicine 322: 1234–1235, 1990
Hellerstrom S. Erythema chronicum migran Afzelius with meningitis. Southern Medical Journal 43: 330–337, 1950
Hellerstrom S. Erythema chronicum migrans Afzelius with meningitis. Acta Dermato-Venereologica 31: 227–234, 1951
Hessler D, zoller L, Sonntag MG. Randomized comparative study of cefotaxime versus penicillin G for late Lyme Borreliosis. Abstract presented at the 16th International Congress on Chemotherapy in Jerusalem, June 11–16, 1989
Horstrup P, Ackermann R. Durch zecker ubertragene Meningopolyneuritis (Garlin-Bujadoux, Bannwarth). Fortschritte der Neurologie-Psychiatrie 41: 583–606, 1973
Johnson RC, Schmid GP, Hyde FW, Steigerwalt AG, Brenner DJ. Borrelia burgdorferisp. nov.: etiologic agent of Lyme disease. International Journal of Systematic Bacteriology 34: 496–497, 1984
Johnson RC, Kodner C, Russel M. In vitroand in vivosusceptibility of the Lyme disease spirochete Borrelia burgdorferi, to four antimicrobial agents. Antimicrobial Agents and Chemotherapy 31: 164–167, 1987
Johnson SE, Klein GC, Schmid GP, Feeley JC. Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. Yale Journal of Biology and Meciine 57: 549–553, 1984
Kauffmann DJH, Wormser G. Ocular Lyme disease: case report and review of the literature. British Journal of Ophthalmology 74: 325–327, 1990
Kimball SA, Janson PA, LaRaia PJ. complete heart block as the sole presentation of Lyme disease. Archives of Internal Medicine 149: 1897–1898, 1989
Kirmser R, Umbach R, Rowett D, Ross A. Complete heart block due to acute non-specific carditis. Chest 71: 682–684, 1977
Kishaba RG, Weinhouse E, Chusid MJ, Nudel DB. Lyme disease presenting as heart block. Clinical Pediatrics 27: 291–293, 1988
Kohler J, Kasper J, Kern U, Thoden U, Rehse-Kupper B. Borrelia encephalomyelitis. Lancet 2: 35, 1986
Lange GE, Schonherr U, Naumann GOH. Retinal vasculitis with proliferative retinopathy in a patient with evidence of Borrelia burgdorferiinfection. American Journal of Ophthalmology 111: 243–244, 1991
Lawson JP, Steere AC. Lyme arthritis: radiologic findings. Radiology 154: 37–45, 1985
Lesser RL, Kornmehl EW, Pachner AR, Kattah J, et al. Neuro-ophthalmologic manifestations of Lyme disease. Ophthalmology 97: 699–706, 1990
Liu NY, Dinerman H, Levin RE, Massarotti E, olloy PJ, et al. Randomized trial of doxycycline vs amoxycillin/probenecid for the treatment of Lyme arthritis: treatment of non-responders with IV penicillin or ceftriaxone. Arthritis and Rheumatism 32: S46, 1989
Lorincz I, Lakos A, Kovacs P, Varvolgyi C, Polgar P, et al. Temporary pacing in complete heart block due to Lyme disease: a case report. PACE Pacing and Clinical Electrophysiology 12: 1433–1436, 1989
Luger SW. Active Lyme Borreliosis in pregnancy: outcomes of six cases with Stage 1, Stage 2, and Stage 3 disease. IV International Conference on Lyme Borreliosis, Stockholm, 1990
MacDonald AB. Human fetal Borreliosis, toxemia of pregnancy, and fetal death. Zbl Bakt Hyg A 263: 189–200, 1986
MacDonald AB, Benach JL, Burgdorfer W. Stillbirth following maternal Lyme disease. New York State Journal of Medicine 87: 615–616, 1987
Marcus LC, Steere AC, Duray PH, Anderson AE, Mahoney EB. Fatal pancarditis in a patient with coexistent Lyme disease and Babesiosis. Annals of Internal Medicine 103: 374–376, 1985
Markowitz LE, Steere AC, Benach JL, Slade JD, Brrome CV. Lyme disease during pregnancy. Journal of the American Medical Association 255: 3394–3396, 1986
Mayer W, Kleber FX, Wilske B. Persistent atrioventricular block in Lyme Borreliosis. Kilinishce Wochenschrift 68: 431–435, 1990
Mayer W, Kleber FX, Wilske B, Preac-Mursic V, Doering W. Variable efficacy of antibiotic therapy in Lyme carditis. IV International Conference on Lyme Borreliosis, Stockholm, 1990
McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Field M, et al. Lyme carditis: an important cause of reversible heart block. Annals of Internal Medicine 110: 339–345 Meissner C, Szer I, Zemel L, Taylor E, Steere A. Amoxicillin or penicillin therapy for Lyme arthritis in children: results from 3 hospitals. Presented at the IV International Conference on Lyme Borreliosis at Stockholm, June 18–21, 1990
Mertz K, Spitalny KC. Epidemiologic notes and reports: imported malaria associated with malariotherapy of Lyme disease — New Jersey. Morbidity and Mortality Weekly Report 39: 873–874, 1990
Murray N, Kristoferitsch W, Stanek G, Steck AJ. Specificity of CSF antibodies against components of Borrelia burgdorferiin patients with meningopolyneuritis Garin-Bujadoux-Bann-warth. Journal of Neurology 233: 224–227, 1986
Nadelman R, Forseter G, Horowitz H, Fish D, Welch P, et al. Single dose doxycycline as prophylaxis for Lyme Borreliosis after I damminibites in a Lyme endemic area. Presented at the IV International Conference on Lyme Borreliosis at Stockholm, June 18–21, 1990
Nishio MJ, Liebling MR, Rodriguez A, Sigal LH, Louie JS. Identification of Borrelia burgdorferiusing interrupted polymerase chain reaction. Arthritis and Rheumatism 33: S84, 1990
Olson LJ, OkafonEC, Clements IP. Cardiac involvement in Lyme disease: Manifestations and management. Mayo Clinic Proceedings 61: 745–749, 1986
Pachner AR. Spirochetal diseases of the central nervous system. Neurologic Clinics 4: 207–222, 1986
Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 35: 47–53, 1985
Pachner AR, Steere AC. CNS manifestations of third stage Lyme disease. Zentralblatt für Bakkteriologie, Mikrobiologie und Hygiene 263: 301–306, 1986
Pal GS, Baker JT, Wright DJM. Penicillin-resistant Borrelia encephalitis responding to cefotaxime. Lancet 1: 50–51, 1988
Peeters AJ, Dijkmans BAC, Sedney MI, et al. Lyme Borreliosis: a hidden cause of heart block in pacemaker treated males. IV International Conference on Lyme Borreliosis, Stockholm, 1990
Pfister HW, Einhaupl KM, Franz P, Garner C. Corticosteroids for radicular pain in Bannwarth’s syndrome. Annals of the New York Academy of Science 539: 485–487, 1988
Pfister H-W, Preac-Mursic V, Wilske B, Einhaupl KM, Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme Borreliosis: a prospective randomized study. Archives of Neurology 46: 1190–1194, 1989
Pfister H-W, Preac-Mursic V, Wilske B, Schielke E, Sorgel F, et al. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. Journal of Infectious Diseases 163: 311–318, 1991
Pikelj F, Strle F, Mozina M. Seronegative Lyme disease and transitory atrioventricular block. Annals of Internal Medicine 111: 90, 1989
Preac-Mursic V, Wilske B, Schierz G. European Borrelia burgdorferiisolated from humans and ticks; culture conditions and antibiotic susceptibility. Zentralblatt für Bakteriologie Mikrobiologie und Hygien (A) 263: 112–118, 1986
Preac-Mursic V, Wilske B, Scherz G, Holmburger M, Suss E. In vitroand in vivosusceptibility of Borrelia burgdorferi. European Journal of Clinical Microbiology 6: 424–426, 1987
Preac-Mursic V, Wilske B, Schierz G, Suss E, Gross B. Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi. European Journal of Clinical Microbiology 8: 651–653, 1989
Reik Jr L, Burgdorfer W, Donaldson JO. Neurologic abnormalities in Lyme disease without erythema chronicum migrans. American Journal of Medicine 81: 73–78, 1986
Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine 58: 281–294, 1979
Reznick JW, Braunstein DB, Walsh RL, et al. Lyme carditis: electrophysiologic and histopathologic study. American Journal of Medicine 81: 923–927, 1986
Ross WH, Sutton HF. Acquired syphilitic uveitis. Archives of Ophthalmology 98: 496–498, 1980
Schechter SL. Lyme disease associated with optic neuropathy. American Journal of Medicine 81: 143–145, 1986
Schlesinger PA, Duray PH, Burke BA, Steere AC, Stillman T. Maternal-fetal transmission of the Lyme disease spiroochete, Borrelia burgdorferi. Annals of Internal Medicine 103: 67–68, 1985
Schmid GP. The global distribution of Lyme disease. Review of Infectious Diseases 7: 41–50, 1985
Sigal LH. Lyme disease: a worldwide Borreliosis. Clinical and Experimental Rheumatology 6: 411–421, 1988
Sigal LH. Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms. Seminars in Arthritis and Rheumatism 18: 151–167, 1989
Sigal LH. Experience with the first one hundred patients referred to a Lyme Disease referral center. American Journal of Medicine 88: 577–581, 1990
Sigal LH. Summary of the Fourth International Symposium on Lyme Borreliosis. Arthritis and Rheumatism 34: 367–370, 1991
Sigal LH. Persisting symptoms in Lyme disease. In Coyle PK (Ed.) Lyme disease, BC Decker, Inc., Philadelphia, 1992
Sigal LH, Curran AS. Lyme disease. Annual Review of Public Health 12: 85–109, 1991
Sigal LH, Tatum AH. Molecular mimicry in Lyme neurologic disease: cross-reactivity between Borrelia burgdorferiand neuronal antigens. Neurology 38: 1439–1442, 1988
Stanek GL, Flamm H, Barbour AG & Burgdorfer W (Eds) Proceedings of the Second International Symposium on Lyme disease and related disorders. Zentralblatt für Bakteriologie, Microbiologie und Hygiene 263: 1–495, 1986
Stanek G, Klein J, Bittner R, Glogar D. Isolation of Borrelia burgdorferifrom the myocardium of a patient with longstanding cardiomyopathy. New England Journal of Medicine 322: 249–252, 1990
Steere AC. Lyme disease. New England Journal of Medicine 321: 586–596, 1989
Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, et al. The early clinical manifestations of Lyme disease. Annals of Internal Medicine 99: 76–82, 1983
Steere AC, Batsford WP, Weinberg M, Alexander J, Berger HJ, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Annals of Internal Medicine 93: 8–16, 1980
Steere AC, Duray P, Kauffmann DJH, Wormser G. Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. Annals of Internal Medicine 103: 382–384, 1
Steere AC, Gibofsky A, Patarroyo ME, Winchester RJ, Hardin JA, et al. Chronic Lyme arthritis, clinical and immunogenetic differentiation from rheumatoid arthritis. Annals of Internal Medicine 90: 896–903, 1979
Steere AC, Green J, Schoen RT, Taylor E, Hutchinson GJ, et al. Successful parenteral penicillin therapy of established Lyme arthritis. New England Journal of Medicine 312: 869–874, 1984
Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, et al. The spirochetal etiology of Lyme Disease. New England Journal of Medicine 308: 733–740, 1983
Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, et al. Treatment of the early manifestations of Lyme disease. Annals of Internal Medicine 99: 22–26, 1983
Steere AC, Malawista SE. Cases of Lyme disease in the United States: location correlated with distribution of Ixodes dammini. Annals of Internal Medicine 91: 730–735, 1979
Steere AC, Malawista SE, Craft JE, Fischer DK, Garcia-Blanco M. (Eds) International Symposium on Lyme disease. Yale Journal of Biology and Medicine 57: 445–705, 1984
Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase PW, et al. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Annals lof Internal Medicine 86: 685–692, 1977
Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis and Rheumatism 20: 7–17, 1977
Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high dose intravenous penicillin. Annals of Internal Medicine 99: 767–772, 1983
Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Annals of Internal Medicine 107: 725–731, 1987
Stiernstedt G. Tick-borne Borreliainfection in Sweden. Scandinavian Journal of Infectious Diseases 45 (Suppl.): 1–70, 1985
Stiernstedt G, Eriksson G, Enfors W, Jorbeck H, Svenungsson B, et al. Erythema chronicum migrans in Sweden: clinical manifestations and antibodies to Ixodes ricinusspirochete. Scandinavian Journal of Infectious Diseases 18: 217–225, 1986
Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B. Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. Journal of Clinical Microbiology 21: 819–825, 1985
Szczepanski A, Benach JL. Lyme Borreliosis: host response to Borrelia burgdorferi.Microbiological Review 55: 21–34, 1991
van der Linde MR, Crijns HJGM, Lie KI. Transient complete AV block in Lyme disease: electrophysiologic observations. Chest 96: 219–221, 1989
van der Linde MR, Crijns HJGM, de Koning J, Hoogkaamp-Korstanje JAA, de Graaf JJ, et al. Range of atrioventricular conduction disturbances in Lyme borreliosis: a report of four cases and review of other published reports. British Heart Journal 63: 162–168, 1990
Vlay SC. Complete heart block due to Lyme disease. New England Journal of Medicine 315: 1418, 1986
Weber K. Lymphocytic meningoradiculitis of Bannwarth and erythema chronicum migrans disease. Journal of Neurology 231: 281–283, 1984
Weber K, Bratzke H-J, Neubert U, Wilske B, Duray PH. Borrelia burgdorferiin a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatric Infectious Diseases 7: 286–289, 1988
Weber K, Neubert U. Clinical features of early erythema chronicum migrans disease and related disorders. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene (A) 263: 209–228, 1986
Williams CL, Strobino B, Weinsten A, Spierling P, Medici F. Lyme disease, pregnancy, and congenital malformations: a cordblood serosurvey. presented at IV International Conference on Lyme Borreliosis, Stockholm, 1990
Wilske B, Schierz G, Preac-Muric V, von Busch K, Kuhbeck R, et al. Intrathecal production of specific antibodies against Borrelia burgdorferiin patients with lymphocytic meningoradiculitis (Bannwarth’s syndrome). Annals of Neurology 20: 337–345, 1986
Winward KE, Smith JL, Culbertson WW, Paris-Hamelin A. Ocular Lyme Borreliosis. American Journal of Ophthalmology 108: 651–657, 1989
Zalneraitis EL, Gerber MA. Prevalence of clinically significant neurologic disorders attributable to congenital Lyme disease. Presented at IV International Conference on Lyme Borreliosis, Stockholm, 1990
Zoller L, Haude M, Hassler D„ Burkhard S, Sontag HG. Spontaneous and post-treatment antibody kinetics in late Lyme borreliosis. Serodiagnosis and Immunotherapy in Infectious Disease 3: 345–353, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sigal, L.H. Current Recommendations for the Treatment of Lyme Disease. Drugs 43, 683–699 (1992). https://doi.org/10.2165/00003495-199243050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199243050-00005